September 29, 2006
September 29, 2006 - The Food and Drug Administration is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Sparhawk Laboratories, Inc. The ANADA provides for use of neomycin sulfate soluble powder in livestock for the treatment and control of bacterial enteritis.
Sparhawk filed ANADA 200-378 for the use of neomycin soluble powder in cattle, swine, sheep, goats and turkeys for the treatment and control of bacterial enteritis. Sparhawk's neomycin soluble powder is approved as a generic copy of NEOMIX 325 (neomycin sulfate) soluble powder, sponsored by Pharmacia & Upjohn Co., a Division of Pfizer, Inc.
This rule is effective Sept. 28, 2006.